Ron Milo served, until recently, as the Chairman of the Department of Neurology and director of the Multiple Sclerosis Center at the Barzilai Medical Center in Ashkelon, the Ben-Gurion University of the Negev, Israel.
Dr. Milo obtained his medical degree from the Hebrew University Hadassah Medical School, Jerusalem. He completed his training in neurology at the Assaf Harofeh Medical Center, Tel Aviv University, and a research fellowship in neuroimmunology at the University of Maryland, Baltimore, where he studied the immunomodulatory properties of interferon-beta and glatiramer acetate in MS. He is involved in basic and clinical research in MS, and has accumulated more than 30 years of experience in conducting clinical trials in MS and other neurological conditions.
Dr Milo’s scientific and clinical interests include the immunology of MS, new therapies in MS, immunomodulation, cognitive dysfunction and the conduction of clinical trials in MS. He is the chairman of the Medical Advisory Board of the Israel MS Society, a Fellow of the American Academy of Neurology (AAN), and a member of the Management Group of the Scientific Panel on MS of the European Academy of Neurology (EAN), council of the European Committee on Treatment and Research in Multiple Sclerosis (ECTRIMS) and the International Medical and Scientific Board (IMSB) of the Multiple Sclerosis International Federation (MSIF).
